Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1995 Jun;95(6):2491–2500. doi: 10.1172/JCI117950

Protease-cleaved iron-transferrin augments oxidant-mediated endothelial cell injury via hydroxyl radical formation.

R A Miller 1, B E Britigan 1
PMCID: PMC295931  PMID: 7769095

Abstract

Previous work has shown that the Pseudomonas-derived protease, pseudomonas elastase (PAE), can modify transferrin to form iron complexes capable of catalyzing the formation of hydroxyl radical (.OH) from neutrophil (PMN)-derived superoxide (.O2-) and hydrogen peroxide (H2O2). As the lung is a major site of Pseudomonas infection, the ability of these iron chelates to augment oxidant-mediated pulmonary artery endothelial cell injury via release of 51Cr from prelabeled cells was examined. Diferrictransferrin previously cleaved with PAE significantly enhanced porcine pulmonary artery endothelial cell monolayer injury from 2.3-6.3 to 15.8-17.0% of maximum, resulting from exposure to H2O2, products of the xanthine/xanthine oxidase reaction, or PMA-stimulated PMNs. Iron associated with transferrin appeared to be responsible for cell injury. Spin trapping and the formation of thiobarbituric acid-reactive 2-deoxyribose oxidation products demonstrated the production of .OH in this system. The addition of catalase, dimethyl thiourea, and the hydrophobic spin trap, alpha-phenyl-n-terbutyl-nitrone, offered significant protection from injury (27.8-58.2%). Since sites of Pseudomonas infection contain other proteases, the ability of porcine pancreatic elastase and trypsin to substitute for PAE was examined. Results were similar to those observed with PAE. We conclude .OH formation resulting from protease alteration of transferrin may serve as a mechanism of tissue injury at sites of bacterial infection and other processes characterized by increased proteolytic activity.

Full text

PDF
2499

Images in this article

2493Image
on p.2493
2494Image
on p.2494
2494Image
on p.2494
2496Image
on p.2496

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amitani R., Wilson R., Rutman A., Read R., Ward C., Burnett D., Stockley R. A., Cole P. J. Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium. Am J Respir Cell Mol Biol. 1991 Jan;4(1):26–32. doi: 10.1165/ajrcmb/4.1.26. [DOI] [PubMed] [Google Scholar]
  2. Aruoma O. I., Halliwell B. Superoxide-dependent and ascorbate-dependent formation of hydroxyl radicals from hydrogen peroxide in the presence of iron. Are lactoferrin and transferrin promoters of hydroxyl-radical generation? Biochem J. 1987 Jan 1;241(1):273–278. doi: 10.1042/bj2410273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baldwin D. A., Jenny E. R., Aisen P. The effect of human serum transferrin and milk lactoferrin on hydroxyl radical formation from superoxide and hydrogen peroxide. J Biol Chem. 1984 Nov 10;259(21):13391–13394. [PubMed] [Google Scholar]
  4. Bedrossian C. W., Greenberg S. D., Singer D. B., Hansen J. J., Rosenberg H. S. The lung in cystic fibrosis. A quantitative study including prevalence of pathologic findings among different age groups. Hum Pathol. 1976 Mar;7(2):195–204. doi: 10.1016/s0046-8177(76)80023-8. [DOI] [PubMed] [Google Scholar]
  5. Bluard-Deconinck J. M., Williams J., Evans R. W., van Snick J., Osinski P. A., Masson P. L. Iron-binding fragments from the N-terminal and C-terminal regions of human lactoferrin. Biochem J. 1978 May 1;171(2):321–327. doi: 10.1042/bj1710321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bodey G. P., Bolivar R., Fainstein V., Jadeja L. Infections caused by Pseudomonas aeruginosa. Rev Infect Dis. 1983 Mar-Apr;5(2):279–313. doi: 10.1093/clinids/5.2.279. [DOI] [PubMed] [Google Scholar]
  7. Borregaard N., Heiple J. M., Simons E. R., Clark R. A. Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: translocation during activation. J Cell Biol. 1983 Jul;97(1):52–61. doi: 10.1083/jcb.97.1.52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Brieland J. K., Clarke S. J., Karmiol S., Phan S. H., Fantone J. C. Transferrin: a potential source of iron for oxygen free radical-mediated endothelial cell injury. Arch Biochem Biophys. 1992 Apr;294(1):265–270. doi: 10.1016/0003-9861(92)90167-u. [DOI] [PubMed] [Google Scholar]
  9. Brines R. D., Brock J. H. The effect of trypsin and chymotrypsin on the in vitro antimicrobial and iron-binding properties of lactoferrin in human milk and bovine colostrum. Unusual resistance of human apolactoferrin to proteolytic digestion. Biochim Biophys Acta. 1983 Sep 13;759(3):229–235. doi: 10.1016/0304-4165(83)90317-3. [DOI] [PubMed] [Google Scholar]
  10. Britigan B. E., Edeker B. L. Pseudomonas and neutrophil products modify transferrin and lactoferrin to create conditions that favor hydroxyl radical formation. J Clin Invest. 1991 Oct;88(4):1092–1102. doi: 10.1172/JCI115408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Britigan B. E., Hayek M. B., Doebbeling B. N., Fick R. B., Jr Transferrin and lactoferrin undergo proteolytic cleavage in the Pseudomonas aeruginosa-infected lungs of patients with cystic fibrosis. Infect Immun. 1993 Dec;61(12):5049–5055. doi: 10.1128/iai.61.12.5049-5055.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Britigan B. E., Rasmussen G. T., Cox C. D. Pseudomonas siderophore pyochelin enhances neutrophil-mediated endothelial cell injury. Am J Physiol. 1994 Feb;266(2 Pt 1):L192–L198. doi: 10.1152/ajplung.1994.266.2.L192. [DOI] [PubMed] [Google Scholar]
  13. Britigan B. E., Roeder T. L., Shasby D. M. Insight into the nature and site of oxygen-centered free radical generation by endothelial cell monolayers using a novel spin trapping technique. Blood. 1992 Feb 1;79(3):699–707. [PubMed] [Google Scholar]
  14. Britigan B. E., Rosen G. M., Chai Y., Cohen M. S. Do human neutrophils make hydroxyl radical? Determination of free radicals generated by human neutrophils activated with a soluble or particulate stimulus using electron paramagnetic resonance spectrometry. J Biol Chem. 1986 Apr 5;261(10):4426–4431. [PubMed] [Google Scholar]
  15. Bruce M. C., Poncz L., Klinger J. D., Stern R. C., Tomashefski J. F., Jr, Dearborn D. G. Biochemical and pathologic evidence for proteolytic destruction of lung connective tissue in cystic fibrosis. Am Rev Respir Dis. 1985 Sep;132(3):529–535. doi: 10.1164/arrd.1985.132.3.529. [DOI] [PubMed] [Google Scholar]
  16. Buettner G. R. The reaction of superoxide, formate radical, and hydrated electron with transferrin and its model compound, Fe(III)-ethylenediamine-N,N'-bis[2-(2-hydroxyphenyl)acetic acid] as studied by pulse radiolysis. J Biol Chem. 1987 Sep 5;262(25):11995–11998. [PubMed] [Google Scholar]
  17. Bullen J. J., Rogers H. J., Griffiths E. Role of iron in bacterial infection. Curr Top Microbiol Immunol. 1978;80:1–35. doi: 10.1007/978-3-642-66956-9_1. [DOI] [PubMed] [Google Scholar]
  18. Busch C., Cancilla P. A., DeBault L. E., Goldsmith J. C., Owen W. G. Use of endothelium cultured on microcarriers as a model for the microcirculation. Lab Invest. 1982 Nov;47(5):498–504. [PubMed] [Google Scholar]
  19. Cabelli D. E., Allen D., Bielski B. H., Holcman J. The interaction between Cu(I) superoxide dismutase and hydrogen peroxide. J Biol Chem. 1989 Jun 15;264(17):9967–9971. [PubMed] [Google Scholar]
  20. Cash H. A., Woods D. E., McCullough B., Johanson W. G., Jr, Bass J. A. A rat model of chronic respiratory infection with Pseudomonas aeruginosa. Am Rev Respir Dis. 1979 Mar;119(3):453–459. doi: 10.1164/arrd.1979.119.3.453. [DOI] [PubMed] [Google Scholar]
  21. Cross C. E., Halliwell B., Borish E. T., Pryor W. A., Ames B. N., Saul R. L., McCord J. M., Harman D. Oxygen radicals and human disease. Ann Intern Med. 1987 Oct;107(4):526–545. doi: 10.7326/0003-4819-107-4-526. [DOI] [PubMed] [Google Scholar]
  22. Dunn M. M., Dunne M., Kamp D. W. Polymorphonuclear leukocyte- and Pseudomonas aeruginosa-induced damage to a human pulmonary epithelial cell line. J Infect Dis. 1990 Jul;162(1):172–177. doi: 10.1093/infdis/162.1.172. [DOI] [PubMed] [Google Scholar]
  23. Döring G., Goldstein W., Röll A., Schiøtz P. O., Høiby N., Botzenhart K. Role of Pseudomonas aeruginosa exoenzymes in lung infections of patients with cystic fibrosis. Infect Immun. 1985 Sep;49(3):557–562. doi: 10.1128/iai.49.3.557-562.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Döring G., Obernesser H. J., Botzenhart K., Flehmig B., Høiby N., Hofmann A. Proteases of Pseudomonas aeruginosa in patients with cystic fibrosis. J Infect Dis. 1983 Apr;147(4):744–750. doi: 10.1093/infdis/147.4.744. [DOI] [PubMed] [Google Scholar]
  25. Döring G., Pfestorf M., Botzenhart K., Abdallah M. A. Impact of proteases on iron uptake of Pseudomonas aeruginosa pyoverdin from transferrin and lactoferrin. Infect Immun. 1988 Jan;56(1):291–293. doi: 10.1128/iai.56.1.291-293.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Esparza I., Brock J. H. The effect of trypsin digestion on the structure and iron-donating properties of transferrins from several species. Biochim Biophys Acta. 1980 Apr 25;622(2):297–307. doi: 10.1016/0005-2795(80)90040-9. [DOI] [PubMed] [Google Scholar]
  27. Evans R. W., Williams J. Studies of the binding of different iron donors to human serum transferrin and isolation of iron-binding fragments from the N- and C-terminal regions of the protein. Biochem J. 1978 Aug 1;173(2):543–552. doi: 10.1042/bj1730543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Fick R. B., Jr, Naegel G. P., Squier S. U., Wood R. E., Gee J. B., Reynolds H. Y. Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis. J Clin Invest. 1984 Jul;74(1):236–248. doi: 10.1172/JCI111407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Fick R. B., Jr Pathogenesis of the pseudomonas lung lesion in cystic fibrosis. Chest. 1989 Jul;96(1):158–164. doi: 10.1378/chest.96.1.158. [DOI] [PubMed] [Google Scholar]
  30. Goldstein W., Döring G. Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis. Am Rev Respir Dis. 1986 Jul;134(1):49–56. doi: 10.1164/arrd.1986.134.1.49. [DOI] [PubMed] [Google Scholar]
  31. Greenwald R. A., Rush S. W., Moak S. A., Weitz Z. Conversion of superoxide generated by polymorphonuclear leukocytes to hydroxyl radical: a direct spectrophotometric detection system based on degradation of deoxyribose. Free Radic Biol Med. 1989;6(4):385–392. doi: 10.1016/0891-5849(89)90084-1. [DOI] [PubMed] [Google Scholar]
  32. Gutteridge J. M., Paterson S. K., Segal A. W., Halliwell B. Inhibition of lipid peroxidation by the iron-binding protein lactoferrin. Biochem J. 1981 Oct 1;199(1):259–261. doi: 10.1042/bj1990259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Halliwell B., Gutteridge J. M. Formation of thiobarbituric-acid-reactive substance from deoxyribose in the presence of iron salts: the role of superoxide and hydroxyl radicals. FEBS Lett. 1981 Jun 15;128(2):347–352. doi: 10.1016/0014-5793(81)80114-7. [DOI] [PubMed] [Google Scholar]
  34. Halliwell B., Gutteridge J. M. Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Arch Biochem Biophys. 1986 May 1;246(2):501–514. doi: 10.1016/0003-9861(86)90305-x. [DOI] [PubMed] [Google Scholar]
  35. Hatanaka M., Tsuboi K. Initiation of wound healing by proteinases released from damaged cells. Int J Tissue React. 1991;13(5):249–255. [PubMed] [Google Scholar]
  36. Heffner J. E., Repine J. E. Pulmonary strategies of antioxidant defense. Am Rev Respir Dis. 1989 Aug;140(2):531–554. doi: 10.1164/ajrccm/140.2.531. [DOI] [PubMed] [Google Scholar]
  37. Holder I. A. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: effect of treatment with protease inhibitors. Rev Infect Dis. 1983 Nov-Dec;5 (Suppl 5):S914–S921. doi: 10.1093/clinids/5.supplement_5.s914. [DOI] [PubMed] [Google Scholar]
  38. Jackson A. H., Hill S. L., Afford S. C., Stockley R. A. Sputum sol-phase proteins and elastase activity in patients with cystic fibrosis. Eur J Respir Dis. 1984 Feb;65(2):114–124. [PubMed] [Google Scholar]
  39. Kreger A. S. Pathogenesis of Pseudomonas aeruginosa ocular diseases. Rev Infect Dis. 1983 Nov-Dec;5 (Suppl 5):S931–S935. doi: 10.1093/clinids/5.supplement_5.s931. [DOI] [PubMed] [Google Scholar]
  40. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  41. Legrand D., Mazurier J., Montreuil J., Spik G. Structure and spatial conformation of the iron-binding sites of transferrins. Biochimie. 1988 Sep;70(9):1185–1195. doi: 10.1016/0300-9084(88)90184-8. [DOI] [PubMed] [Google Scholar]
  42. Meyer K. C., Lewandoski J. R., Zimmerman J. J., Nunley D., Calhoun W. J., Dopico G. A. Human neutrophil elastase and elastase/alpha 1-antiprotease complex in cystic fibrosis. Comparison with interstitial lung disease and evaluation of the effect of intravenously administered antibiotic therapy. Am Rev Respir Dis. 1991 Sep;144(3 Pt 1):580–585. doi: 10.1164/ajrccm/144.3_Pt_1.580. [DOI] [PubMed] [Google Scholar]
  43. Mohammed J. R., Mohammed B. S., Pawluk L. J., Bucci D. M., Baker N. R., Davis W. B. Purification and cytotoxic potential of myeloperoxidase in cystic fibrosis sputum. J Lab Clin Med. 1988 Dec;112(6):711–720. [PubMed] [Google Scholar]
  44. Pier G. B. Pulmonary disease associated with Pseudomonas aeruginosa in cystic fibrosis: current status of the host-bacterium interaction. J Infect Dis. 1985 Apr;151(4):575–580. doi: 10.1093/infdis/151.4.575. [DOI] [PubMed] [Google Scholar]
  45. Ramos C. L., Pou S., Britigan B. E., Cohen M. S., Rosen G. M. Spin trapping evidence for myeloperoxidase-dependent hydroxyl radical formation by human neutrophils and monocytes. J Biol Chem. 1992 Apr 25;267(12):8307–8312. [PubMed] [Google Scholar]
  46. Reichart E., Boerkmann P., Plenat F. Parenteral administration of trypsin triggers lung emphysema. Eur Respir J. 1992 Jul;5(7):810–814. [PubMed] [Google Scholar]
  47. Reynolds H. Y. Bronchoalveolar lavage. Am Rev Respir Dis. 1987 Jan;135(1):250–263. doi: 10.1164/arrd.1987.135.1.250. [DOI] [PubMed] [Google Scholar]
  48. Sibille Y., Reynolds H. Y. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis. 1990 Feb;141(2):471–501. doi: 10.1164/ajrccm/141.2.471. [DOI] [PubMed] [Google Scholar]
  49. Stern R. C., Wood R. E., Boat T. F., Matthews L. W., Tucker A. S., Doershuk C. F. Treatment and prognosis of massive hemoptysis in cystic fibrosis. Am Rev Respir Dis. 1978 May;117(5):825–828. doi: 10.1164/arrd.1978.117.5.825. [DOI] [PubMed] [Google Scholar]
  50. Stone P. J., Franzblau C., Kagan H. M. Proteolysis of insoluble elastin. Methods Enzymol. 1982;82(Pt A):588–605. doi: 10.1016/0076-6879(82)82089-2. [DOI] [PubMed] [Google Scholar]
  51. Suter S., Schaad U. B., Roux L., Nydegger U. E., Waldvogel F. A. Granulocyte neutral proteases and Pseudomonas elastase as possible causes of airway damage in patients with cystic fibrosis. J Infect Dis. 1984 Apr;149(4):523–531. doi: 10.1093/infdis/149.4.523. [DOI] [PubMed] [Google Scholar]
  52. Suter S., Schaad U. B., Tegner H., Ohlsson K., Desgrandchamps D., Waldvogel F. A. Levels of free granulocyte elastase in bronchial secretions from patients with cystic fibrosis: effect of antimicrobial treatment against Pseudomonas aeruginosa. J Infect Dis. 1986 May;153(5):902–909. doi: 10.1093/infdis/153.5.902. [DOI] [PubMed] [Google Scholar]
  53. Suter S. The imbalance between granulocyte neutral proteases and antiproteases in bronchial secretions from patients with cystic fibrosis. Antibiot Chemother (1971) 1989;42:158–168. doi: 10.1159/000417616. [DOI] [PubMed] [Google Scholar]
  54. Ward P. A. Mechanisms of endothelial cell injury. J Lab Clin Med. 1991 Nov;118(5):421–426. [PubMed] [Google Scholar]
  55. Ward P. A., Till G. O., Kunkel R., Beauchamp C. Evidence for role of hydroxyl radical in complement and neutrophil-dependent tissue injury. J Clin Invest. 1983 Sep;72(3):789–801. doi: 10.1172/JCI111050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Winterbourn C. C. Lactoferrin-catalysed hydroxyl radical production. Additional requirement for a chelating agent. Biochem J. 1983 Jan 15;210(1):15–19. doi: 10.1042/bj2100015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Wretlind B., Pavlovskis O. R. Pseudomonas aeruginosa elastase and its role in pseudomonas infections. Rev Infect Dis. 1983 Nov-Dec;5 (Suppl 5):S998–1004. doi: 10.1093/clinids/5.supplement_5.s998. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES